» Articles » PMID: 12832972

Postoperative Cytology for Drained Fluid from the Pancreatic Bed After "curative" Resection of Pancreatic Cancers: Does It Predict Both the Patient's Prognosis and the Site of Cancer Recurrence?

Overview
Journal Ann Surg
Specialty General Surgery
Date 2003 Jul 2
PMID 12832972
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the postoperative cytology of drained fluid from the pancreatic bed as a predictive indicator of local recurrence after curative (R0) resection of pancreatic cancer.

Summary Background Data: The pancreatic bed offers a common site of cancer recurrence (local recurrence), even after curative (R0) resection is performed for pancreatic cancer. If local recurrence is thereby predicted precisely, soon after surgery, we have a chance to treat it by adding radiation or some other locoregional therapy before it can grow or spread beyond the pancreatic bed. However, there have been no previous reports of cytology performed on the drained fluid after pancreatectomy.

Methods: This study includes 94 patients who had shown negative results in the peritoneal washing cytology before resection and subsequently received pancreatectomies for pancreatic tumors. They consisted of 12 benign tumors, 17 noninvasive or minimally invasive carcinomas and 65 invasive ductal carcinomas (R0 = 58; R1/2 = 7). Postoperatively, the drained fluid from the pancreatic bed was collected for 24 hours and used for cytologic examination. The cytologic results were examined in association with the histopathology of the resected tumor, patient's survival, and mode of cancer recurrence, including local recurrence.

Results: Patients with benign tumors or noninvasive/minimally invasive carcinomas had negative result in cytology, and none of them have died of local recurrence (limited to the pancreatic bed) to date. However, patients with invasive ductal carcinoma revealed higher cytology-positive rates: 28% (16/58) in curative (R0) resection; and 71% (5/7) in noncurative (R1/2) resection. Among 58 patients with R0 resection, the 3-year survival rate was 14% in 16 cytology-positive patients and 55% in 42 cytology-negative patients (P < 0.05). The 3-year cumulative rate of local recurrence was 85% and 23%, respectively (P < 0.05). Compared with other histopathologic parameters obtained from the resected specimens, the drain cytology was more specific in predicting the subsequent development of local recurrence.

Conclusions: Drain-cytology was a quick examination that enabled us to specifically indicate both minute residual cancer and subsequent development of local recurrence even after R0 resection of pancreatic cancer.

Citing Articles

Factors Affecting Positive Peritoneal Lavage Cytology in Patients with Stage II and III Colorectal Cancer with R0 Resection: A Multi-institutional, Prospective Study.

Sato H, Kotake K, Maeda K, Kobayashi H, Takahashi H, Sugihara K J Anus Rectum Colon. 2021; 5(4):355-365.

PMID: 34746500 PMC: 8553352. DOI: 10.23922/jarc.2021-006.


ISOlation Procedure vs. conventional procedure during Distal Pancreatectomy (ISOP-DP trial): study protocol for a randomized controlled trial.

Okada K, Kawai M, Hirono S, Sho M, Tani M, Matsumoto I Trials. 2021; 22(1):633.

PMID: 34530885 PMC: 8447574. DOI: 10.1186/s13063-021-05523-y.


Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients.

Dhayat S, Tamim A, Jacob M, Ebeling G, Kerschke L, Kabar I PLoS One. 2021; 16(6):e0252727.

PMID: 34086792 PMC: 8177431. DOI: 10.1371/journal.pone.0252727.


Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.

Ariake K, Motoi F, Ohtsuka H, Fukase K, Masuda K, Mizuma M Surg Today. 2017; 47(12):1434-1442.

PMID: 28434080 DOI: 10.1007/s00595-017-1531-9.


Original Scientific Reports: Clinicopathological Findings of Remnant Pancreatic Cancers in Survivors Following Curative Resections of Pancreatic Cancers.

Suzuki S, Furukawa T, Oshima N, Izumo W, Shimizu K, Yamamoto M World J Surg. 2015; 40(4):974-81.

PMID: 26589594 PMC: 4767846. DOI: 10.1007/s00268-015-3353-5.


References
1.
Ishikawa O, Ohigashi H, Sasaki Y, Nakano H, Furukawa H, Imaoka S . Intraoperative cytodiagnosis for detecting a minute invasion of the portal vein during pancreatoduodenectomy for adenocarcinoma of the pancreatic head. Am J Surg. 1998; 175(6):477-81. DOI: 10.1016/s0002-9610(98)00079-8. View

2.
Leach S, Rose J, Lowy A, Lee J, Charnsangavej C, Abbruzzese J . Significance of peritoneal cytology in patients with potentially resectable adenocarcinoma of the pancreatic head. Surgery. 1995; 118(3):472-8. DOI: 10.1016/s0039-6060(05)80361-7. View

3.
Ohigashi H, Ishikawa O, Sasaki Y, Yamada T, Furukawa H, Imaoka S . K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors. Arch Surg. 2000; 135(12):1450-5. DOI: 10.1001/archsurg.135.12.1450. View

4.
Doki Y, Kabuto T, Ishikawa O, Ohigashi H, Sasaki Y, Yamada T . Does pleural lavage cytology before thoracic closure predict both patient's prognosis and site of cancer recurrence after resection of esophageal cancer?. Surgery. 2001; 130(5):792-7. DOI: 10.1067/msy.2001.117195. View

5.
. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer. 1987; 59(12):2006-10. DOI: 10.1002/1097-0142(19870615)59:12<2006::aid-cncr2820591206>3.0.co;2-b. View